Pharmaceutical scientist, biotech founder, and weekly columnist for Makkah Newspaper writing on the medicine, money, and machinery shaping the next decade of healthcare.
Nabil Alhakamy writes a weekly opinion column for Makkah Newspaper at the intersection of pharmaceutical innovation, biotechnology investment, healthcare policy, and the emerging economy.
He serves as a professor at the Faculty of Pharmacy, King Abdulaziz University, and is co-founder of multiple Saudi and U.S. health and Pharma/biotech ventures.
A TEDx speaker, he has shared the stage at TEDx on translating pharmaceutical research into the public conversation.
His writing draws on three decades at the boundary between Saudi pharma, academic research, and global biotech entrepreneurship, translating what happens inside laboratories, boardrooms, and regulators into a public conversation any reader can follow.
In the Kingdom, we have moved mountains of sand and seas of oil. The next thing we move must be medicine itself, not from the laboratory outward, but from the conversation inward, where science, capital, and the patient finally speak the same language.— Nabil Alhakamy